始めましょう
ReutersReuters

Synmosa Biopharma Plans To Acquire Up To 30% Stake Of Genovate Biotechnology

Refinitiv1分未満で読めます
41144130

Synmosa Biopharma 4114:

  • PLANS TO ACQUIRE UP TO 34.466 MILLION SHARES, OR 30% STAKE, OF GENOVATE BIOTECHNOLOGY 4130 BIDDING T$24 ($0.8) PER SHARE IN TAIWAN STOCK MARKET

  • PLANS TO BID FOR THE GENOVATE SHARES FROM SEPT 17 TO OCT 7

  • PLAN TO ACQUIRE THE STAKE IN GENOVATE AIMS TO SHARE RESOURCES, CREATE SCALE EFFICIENCY

Reutersアジア台湾株財務諸表
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
ログイン、もしくは永年無料のアカウントを作成して、このニュースを読みましょう

Reutersからその他のニュース